PubRank
Search
About
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
Clinical Trial ID NCT00338377
PubWeight™ 12.16
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00338377
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Clin Cancer Res
2012
1.90
2
Treatment of cutaneous melanoma: current approaches and future prospects.
Cancer Manag Res
2010
1.01
3
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy.
Clin Cancer Res
2012
0.98
4
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.
Cancer Biol Med
2014
0.95
5
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Clin Cancer Res
2011
0.93
6
Optimizing dendritic cell-based approaches for cancer immunotherapy.
Yale J Biol Med
2014
0.85
7
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.
Semin Oncol
2015
0.82
8
Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.
Front Immunol
2015
0.82
9
Targeting CD8+ T-cell tolerance for cancer immunotherapy.
Immunotherapy
2014
0.81
10
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
BMC Med
2016
0.78
11
Immunotherapy in pediatric malignancies: current status and future perspectives.
Future Oncol
2014
0.78
12
Update on use of aldesleukin for treatment of high-risk metastatic melanoma.
Immunotargets Ther
2015
0.76
13
The Role of Adaptive Immunity in the Efficacy of Targeted Cancer Therapies.
Trends Immunol
2016
0.75
Next 100